Our mission is to strategically partner with scientists, engineers and clinicians to translate dental, oral and craniofacial tissue engineering and regenerative medicine technologies to clinical practice. We assist by building a customized approach for success utilizing an innovative toolkit, access to an exclusive mentorship and an expansive community of translational resources.
The MPWRM Interdisciplinary Translational Project (ITP) Program provides funding to support translational research projects focused on DOC tissues. The goal of this program is to support research that addresses unmet clinical needs and leads to improvements in dental, oral and craniofacial therapies. Capped at $150,000, awards are intended to achieve a key milestone or accelerate technology translation leading to the submission of Investigational New Drug (IND)/Investigational Device Exemption (IDE) applications to the U.S. Food and Drug Administration to eventually impact clinical practice.
Stay updated on the latest news and developments of the MPWRM.
For more information about the MPWRM please click below.
NEWS & EVENTS
Read about the latest news and developments.